Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancer

Leslie Randall, Yang Xiang, Takashi Matsumoto, Diana Giannarelli, Dency Pilar Milla, Karla Alejandra Lopez, Alejandro Acevedo, Julia Vizkeleti, Ritu Salani, Angelica Nogueira-Rodrigues, Fernando Contreras Mejia, Jacob Korach, Hüseyin Akilli, Jung-Yun Lee, Valeriya Vladimirovna Saevets, Vanessa Samouelian, Jalid Sehouli, Ekkasit Tharavichikul, Vladyslav Sukhin, Nicoletta Colombo, Chih-Long Chang, Juan F. Cueva, Susan Lalondrelle, Edgar Petru, Elizabeth Szamreta, Allison Martin Nguyen, Karin Yamada, Kan Li, Sandro Pignata, Domenica Lorusso

Open source

DOI: 10.1016/j.ygyno.2025.06.003
Published: 2025-08
Container: Gynecologic Oncology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ygyno.2025.06.003,
  title = {Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancer},
  author = {Leslie Randall and Yang Xiang and Takashi Matsumoto and Diana Giannarelli and Dency Pilar Milla and Karla Alejandra Lopez and Alejandro Acevedo and Julia Vizkeleti and Ritu Salani and Angelica Nogueira-Rodrigues and Fernando Contreras Mejia and Jacob Korach and Hüseyin Akilli and Jung-Yun Lee and Valeriya Vladimirovna Saevets and Vanessa Samouelian and Jalid Sehouli and Ekkasit Tharavichikul and Vladyslav Sukhin and Nicoletta Colombo and Chih-Long Chang and Juan F. Cueva and Susan Lalondrelle and Edgar Petru and Elizabeth Szamreta and Allison Martin Nguyen and Karin Yamada and Kan Li and Sandro Pignata and Domenica Lorusso},
  year = {2025},
  journal = {Gynecologic Oncology},
  doi = {10.1016/j.ygyno.2025.06.003},
  url = {https://doi.org/10.1016/j.ygyno.2025.06.003}
}

RIS

TY  - JOUR
TI  - Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancer
AU  - Leslie Randall
AU  - Yang Xiang
AU  - Takashi Matsumoto
AU  - Diana Giannarelli
AU  - Dency Pilar Milla
AU  - Karla Alejandra Lopez
AU  - Alejandro Acevedo
AU  - Julia Vizkeleti
AU  - Ritu Salani
AU  - Angelica Nogueira-Rodrigues
AU  - Fernando Contreras Mejia
AU  - Jacob Korach
AU  - Hüseyin Akilli
AU  - Jung-Yun Lee
AU  - Valeriya Vladimirovna Saevets
AU  - Vanessa Samouelian
AU  - Jalid Sehouli
AU  - Ekkasit Tharavichikul
AU  - Vladyslav Sukhin
AU  - Nicoletta Colombo
AU  - Chih-Long Chang
AU  - Juan F. Cueva
AU  - Susan Lalondrelle
AU  - Edgar Petru
AU  - Elizabeth Szamreta
AU  - Allison Martin Nguyen
AU  - Karin Yamada
AU  - Kan Li
AU  - Sandro Pignata
AU  - Domenica Lorusso
PY  - 2025
JO  - Gynecologic Oncology
DO  - 10.1016/j.ygyno.2025.06.003
UR  - https://doi.org/10.1016/j.ygyno.2025.06.003
ER  -

APA

Randall, L., Xiang, Y., Matsumoto, T., Giannarelli, D., Milla, D. P., Lopez, K. A., Acevedo, A., Vizkeleti, J., Salani, R., Nogueira-Rodrigues, A., Mejia, F. C., Korach, J., Akilli, H., Lee, J., Saevets, V. V., Samouelian, V., Sehouli, J., Tharavichikul, E., Sukhin, V., Colombo, N., Chang, C., Cueva, J. F., Lalondrelle, S., Petru, E., Szamreta, E., Nguyen, A. M., Yamada, K., Li, K., Pignata, S., & Lorusso, D. (2025). Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancer. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2025.06.003

Source records

crossref · retrieved 2026-09-26T07:41:25.654Z